By modulating the cAMP/protein kinase A (PKA)/CREB or cGMP/PKG/CREB pathway, these enzymes influence the phosphorylation of CREB at Ser133 and dopamine- and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) at Thr34, which are pivotal for the transcription of neurotrophic factors such as brain-derived neurotrophic factor (BDNF), thereby impacting neuroplasticity and synaptic integrity (Morimoto and Koshland, 1991
Short-Term Effects: Hypoglycemia (low blood sugar) Nausea or headaches Water retention and bloating Joint discomfort Redness or irritation at injection site Long-Term or Serious Risks: Organ enlargement (heart, liver, spleen) Increased tumor risk can stimulate dormant or precancerous cells Insulin resistance and possible onset of type 2 diabetes Hormonal imbalance from growth pathway overstimulation Bottom line: IGF-1 LR3 is potent, but it doesnt discriminate between good and bad cell growth
Features Benefits These statements have not been evaluated by the Food and Drug Administration
10.1089/ars.2016.6866 82 YuF.YuC.LiF.ZuoY.WangY.YaoL.et al (2021)
Research published in the European Journal of Endocrinology confirmed that even at doses more than 200-fold higher than needed for GH release, Ipamorelin did not affect ACTH or cortisol levelsa selectivity similar to natural GHRH itself
